Abstract. The aim of the present study was to investigate the effects of lysyl oxidase-like 2 (LOXL2) on the invasion, migration and epithelial-to-mesenchymal transition (EMT) of renal cell carcinoma (RCC) cells through the steroid receptor coactivator (Src)/focal adhesion kinase (FAK) signaling pathway. RCC tissues and adjacent normal tissues were collected from 80 patients with RCC. Immunohistochemistry was used to determine the positive expression rate of the LOXL2 protein. The expression levels of LOXL2 in the HK-2, 786-O, ACHN, Caki1 and A498 cell lines were detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The high LOXL2-expressing 786-O cells were selected for gene silencing experiments, whereas Caki1 cells, which exhibited low LOXL2 expression, were used for overexpression experiments. RT-qPCR and western blot analysis were applied to determine the expression of LOXL2, FAK, Src, matrix metalloproteinase (MMP)-9, epithelial (E)-cadherin, neuronal (N)-cadherin and vimentin. A MTT assay, a Transwell assay, a wound healing assay and flow cytometry were performed to detect cell proliferation, invasion, migration, cell cycle distribution and apoptosis, respectively. The protein expression rate of LOXL2 in RCC tissues was higher compared with that in adjacent normal tissues. Compared with adjacent normal tissues, the mRNA and protein expression levels of LOXL2, FAK, Src, MMP-9, N-cadherin and vimentin and the levels of FAK and Src phosphorylation were increased, while the mRNA and protein expression levels of E-cadherin were decreased in RCC tissues. Following the transfection of 786-O cells with small interfering (si) RNA against LOXL2, the mRNA and protein expression levels of FAK, Src, MMP-9, N-cadherin and vimentin and the levels of phosphorylated FAK and Src were notably decreased in the si-LOXL2 and PP2 inhibitor treated groups, while that of E-cadherin was substantially increased. Additionally, cell proliferation, invasion, migration and the percentage of RCC cells in the G1 phase were reduced, and cell apoptosis was increased. Additionally, Caki1 cells transfected with LOXL2 exhibited an opposite trend. In summary, these results indicate that LOXL2 silencing inhibits the invasion, migration and EMT in RCC cells through inhibition of the Src/FAK signaling pathway.
Introduction
Renal cell carcinoma (RCC) is a complex disease entity comprising different types of cancer occurring in the kidney, each of which results from a different gene, with different histological characteristics and a clinical course that responds differently to therapy (1) . Over the past two decades, the incidence of RCC has increased due to an increasing number of patients diagnosed with small kidney tumor types (2) . The overall lifetime risk for RCC development is ~1 in 67, and it is higher in men compared with women (3). Due to its gradual onset and progression, RCC may be difficult to detect and ~80% of renal tumor types are discovered incidentally during unassociated abdominal imaging examinations (4) . Among all RCCs, clear cell RCC is the most frequently occurring type, accounting for >90% of all cases (5) . The risk factors for RCC may vary, including smoking, obesity, hypertension, dietary habits and living environment (6) . Diverse treatments for RCC have been reported, including the use of drugs, virus-based gene therapies and ablative therapies, in addition to preoperative tumor embolization (7) (8) (9) (10) . However, novel therapies are required due to the complexity and poor prognosis of RCC.
The lysyl oxidase-like 2 (LOXL2) protein is a type of human paralogue of lysyl oxidase (LOX) that functions as an amine oxidase and aids the formation of lysine-derived cross-links in collagen and elastin (11) . At present, LOXL2 is considered to be responsible for a diverse range of cellular functions, including cell adhesion, migration and invasion, metastasis, epithelial-to-mesenchymal transition (EMT) and malignant transformation (12) . Downregulated LOXL2 expression is
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XI HONG 1 and JIAN-JUN YU reported to inhibit cell migration and invasion in RCC (13) . The steroid receptor coactivator (Src)/focal adhesion kinase (FAK) signaling pathway is known to be involved in the migration and invasion of various tumor cell types (14) . A previous study reported that the inhibition of Src may represent a promising option for the treatment of RCC (15) . Accumulating evidence indicates a potential association between LOXL2 and the Src/FAK signaling pathway, as tumor-secreted LOXL2 is able to activate fibroblasts through FAK signaling, and LOXL2 is capable of activating the FAK/protein kinase B (AKT)/mammalian target of rapamycin signaling pathways (16, 17) . However, few studies investigating LOXL2 and the Src-AKT signaling pathway in RCC have been conducted to date. Therefore, the aim of the present study was to investigate the effect of LOXL2 on the invasion, migration and EMT of RCC cells through the Src/FAK signaling pathway, in order to identify novel potential targets for the treatment of RCC.
Materials and methods
Ethics statement. Hematoxylin and eosin (H&E) staining. The tissue specimens were fixed in 10% neutral formaldehyde for 16-18 h at room temperature, dehydrated through graded ethanol (50, 70, 80, 90 and 100%), transparentized in xylene at 35˚C for 30 min and embedded in paraffin at 60˚C for 30 min. Subsequently, the specimens were sliced into serial sections at a thickness of 5 µm and allowed to stand at 45˚C. Next, the sections were extracted, baked at 60˚C for 1 h, deparaffinized by washing with xylene and rehydrated. Then, H&E staining was performed at a temperature of 35˚C as follows: the sections were stained by hematoxylin for 10 min, washed with water for 15 min, differentiated with 1% hydrochloric acid-ethanol for 3 sec, washed with water for 10 sec and stained with 0.5% eosin for 3 min (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China). Then, the sections were dehydrated with graded ethanol, transparentized with xylene and sealed with neutral gum. The pathological changes of the RCC tissues and adjacent normal tissues were observed under an optical microscope (magnification, x200) (CX31-LV320; Olympus Corporation, Tokyo, Japan).
Immunohistochemistry. The tissues were embedded in paraffin and sliced into 3-4-µm sections. The sections were deparaffinized and hydrated at room temperature for 20 min. Subsequently, the endogenous peroxidase activity was blocked in 3% H 2 O 2 at room temperature for 10 min while the sections were processed for antigen retrieval in a microwave at a power of 800 W at 90˚C for 5 min. Next, the sections were blocked with 10% goat serum and incubated at room temperature for 10 min. Primary polyclonal rabbit anti-human LOXL2 antibody (1:100; cat no. ab179810; Abcam, Cambridge, MA, USA) was added to the sections and left overnight at 4˚C. Secondary biotinylated goat anti-rabbit immunoglobulin G (IgG) antibody (1:1,000; cat no. ab6789; Abcam) was added to the sections for 30 min at 37˚C. Next, hematoxylin (cat no. C0105. Beyotime Institute of Biotechnology, Shanghai, China) was used to counterstain the nuclei for 30 sec at 37˚C, followed by 3,3'-diaminobenzidine (cat no. P0202; Beyotime Institute of Biotechnology) staining at 37˚C for 10 min. Subsequently, the sections were dehydrated with hydrochloric acid ethanol to clear and sealed with gum. Images were captured under an optical microscope (magnification, x200) (Olympus Corporation), and analyzed using Image-Pro Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA). Brown-yellow cytoplasmic staining was classified as a positive expression.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Frozen tissues (100 mg) were obtained and a TRIzol ® kit (cat no. 16096020; Thermo Fisher Scientific, Inc., Waltham, MA, USA) was employed to extract total RNA, according to the manufacturer's protocol. The primers were designed by the biological software packages Primer Premier 5 (Premier Biosoft International, Palo Alto, CA, USA) and Oligo 6.0 software (Molecular Biology Insights Inc., Cascade, CO, USA) and synthesized by Takara Biotechnology Co., Ltd. (Dalian, China), and are presented in Table I . RNA (10 µl) was extracted and diluted by RNase-free ultra-pure water (x20). The optical density (OD) at 260 nm and 280 nm was recorded with an ultraviolet/visible spectrophotometer, and the concentration and purity of the total RNA were measured. Next, 5 µl Mix reagent (cat no. 4368702; Tideradar Beijing Technology Co., Ltd., Beijing, China), 5 µl total RNA and 10 µl RNase-free H 2 O were added into an Eppendorf tube, mixed by centrifugation (7, 200 x g at 4˚C for 1 min) and placed in a qPCR instrument. The reaction conditions were as follows: 37˚C for 15 min and 85˚C for 5 sec; and the reaction was terminated at 4˚C. The cDNA obtained by RT was stored at -20˚C. The ABI7500 qPCR instrument (ABI 7500; Applied Biosystems; Thermo Fisher Scientific, Inc.) was used for RT-qPCR and the reaction conditions were as follows: Pre-denaturation at 95˚C for 10 min and a total of 40 cycles of denaturation at 95˚C for 10 sec, annealing at 60˚C for 20 sec and extension at 72˚C for 34 sec. SYBR Green fluorescence dye (Takara Biotechnology Co., Ltd.) was applied for RT-qPCR, which was also suitable for cell detection at 48 h of transfection. The expression levels were evaluation by 2 -ΔΔCq method (20) .
Western blot analysis. The RCC tissues and adjacent normal tissues were added to liquid nitrogen and ground into a homogeneous fine powder. Protein lysate was added (cat no. C0481; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) to the tissues at 4˚C for 30 min and centrifugation was conducted at 29,000 x g at 4˚C for 20 min. Next, the supernatant was collected and packaged separately for further use. The bicinchoninic acid method was used to measure the protein concentration of each sample and deionized water was used for adjustment, in order to maintain consistency with the volume of the loading sample. Subsequently, proteins were separated by SDS-PAGE (10% gels). Gene Sequence
LOXL2, lysyl oxidase-like 2; FAK, focal adhesion kinase; MMP-9, matrix metalloproteinase-9; N-cadherin, neuronal cadherin; E-cadherin, epithelial cadherin; F, forward; R, reverse. /well) at 37˚C in a humidified atmosphere containing 5% CO 2 . The culture medium was changed every 2-3 days. The cells were subcultured until they reached 80-90% confluence. The culture medium was then removed and the cells were washed with PBS twice, digested with 0.25% trypsin for 2-5 min at 37˚C, resuspended and subcultured in 5 ml RPMI-1640 containing 10% FBS.
Cells in the logarithmic growth phase were extracted and assigned into the following groups Thermo Fisher Scientific, Inc.) was used to dilute 100 pmol blank adenovirus vector Ad-CMV-eGFP, siRNA-LOXL2 and Ad-CMV-LOXL2-eGFP solutions (final concentration, 50 nM), which were gently mixed and incubated at room temperature for 5 min. Next, 250 µl serum-free Opti-MEM was used to dilute 5 µl Lipofectamine 2000 and the two solutions were mixed and incubated at room temperature for 5 min. Subsequent to combining the two mixtures, the solution was incubated at room temperature for 20 min and added into the wells of a cell culture plate. The transfected cells were then cultured in an incubator at 37˚C in a humidified atmosphere containing 5% CO 2 . After 6-8 h of culture, cells were resuspended in complete medium. The eGFP protein expression in the cells was observed under a fluorescence microscope (magnification, x100) (M30C; Shanghai Wan Heng Precision Instrument Co., Ltd., Shanghai, China) after a 24-h culture; two random fields were selected for image capture and the mean value was calculated. The transfection efficiency was equal to the ratio of the number of transfected cells to that of total cells. After 24-48-h culturing, the cells were used for further experiments.
MTT assay. Following transfection for 24 h, RCC cells in the logarithmic growth phase were collected and RPMI-1640 containing 10% FBS was used to prepare the cell suspension (2.5x10 5 /ml). The cells were seeded into a 96-well plate, and 8-wells were set for each group (100 µl/well); the plate was then incubated at 37˚C in a humidified atmosphere containing 5% CO 2 for 24, 48 and 72 h. Next, 10 µl MTT solution (5 mg/ml; Sigma-Aldrich; Merck KGaA) was added to each well for another 4-h culture. Once the culture was terminated, the supernatant was discarded and 150 µl dimethyl sulfoxide solution was added to the plate and vibrated for 10 min to dissolve crystals at room temperature. A microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to measure the optical density (OD) value of each well at 490 nm. Three parallel wells were set for each group and the mean value was calculated. The experiment was repeated three times. The curve of cell proliferation was drawn with time as the abscissa and the OD value as the ordinate.
Transwell assay. The RCC cells were dissolved with Matrigel (cat no. 356234; BD Biosciences, San Jose, CA, USA) overnight, and diluted with serum-free DMEM (Gibco; Thermo Fisher Scientific, Inc.) at dilution ratio of 1:3. Next, 50 µl diluted Matrigel was added into the upper Transwell chamber and allowed to stand in an incubator for 30 min at 37˚C. The upper chamber (with serum-free medium) was inoculated with a ~1x10 5 /ml cell suspension and the DMEM medium containing 10% FBS was added to the basolateral Transwell chamber. After a 24-h culture at 37˚C, the chambers were washed twice with PBS. Cells were removed from the top of the membranes with a cotton swab. Invading cells were fixed with 5% glutaraldehyde at 4˚C for 30 min and stained with 0.1% crystal violet (Sigma-Aldrich; Merck KGaA) at 37˚C for 10 min. The number of invading cells was counted and used as the indicator to evaluate cell invasion and migration ability. Images were captured under an optical microscope (magnification, x200; Olympus Corporation). The experiment was repeated three times.
Wound healing assay. The RCC cells were seeded in a 6-well plate. Serum-free DMEM was used following cell attachment. When the cell confluence reached 90-100%, a pipette tip (10 µl) was used to scratch the 6-well plate perpendicular to the bottom of the plate, with 4-5 lines per well, ensuring that the width of all scratches was uniform. Once the cells were rinsed using PBS three times, the scratched cells were removed and cultured in an incubator. Migration distance at the scratch region was determined under an optical microscope (magnification, x100) at 0 and 24 h, and six horizontal lines were randomly drawn and then photographed. The scratch gap confluence rate was calculated as follows: Gap confluence rate = (gap width at 0 h -gap width at 24 h)/gap width at 0 h. Three duplicated wells were set in each well and the experiment was repeated three times.
Flow cytometry. The culture medium was discarded 48 h after transfection. A total of 1x10 5 /ml RCC cells were then washed once with PBS balanced salt solution and digested using 0.25% trypsin. When the cells acquired a round shape, trypsin was removed and the DMEM medium containing 10% FBS was added to the cells to terminate digestion. Next, the cells were mixed to prepare a mixed cell suspension, which was centrifuged at 200 x g for 5 min at 4˚C, and then the supernatant was discarded. PBS balanced salt solution was used to wash the cells twice and precooled 70% ethanol was used to fix the cells for 30 min at 4˚C, following which the cells were collected by centrifugation at 200 x g for 5 min at 4˚C. Subsequently, PBS solution was added to wash the cells twice, and 1 ml propidium iodide (PI) with RNAse was used for staining for 30 min at 37˚C. The cells were washed with PBS balanced salt solution twice and PI was removed. The volume of the mixture solution was adjusted to 1 ml with the addition of PBS solution. The samples were transferred to a flow cytometry instrument (BD-Aria; FACS Calibur; Beckman Coulter, Miami, FL, USA) in order to record cell cycle at the activating wavelength of 488 nm detected by red fluorescence. Three samples were set in each group and the experiment was repeated three times.
At 48 h a f t er t ra nsfe ct ion, t r y psi n wit hout ethylenediaminetetraacetic acid was applied to digest the cells for 5 min at 37˚C, and the cells were then collected into a flow tube. Next, centrifugation was performed and the supernatant was removed. The cells were washed with cold PBS three times, followed by centrifugation at 200 x g for 5 min at 4˚C and supernatant removal. Subsequently, Annexin V-fluorescein isothiocyanate (FITC) dye solution was prepared by Annexin V-FITC, PI and HEPES buffer solution at 1:2:50 using the Annexin-V-FITC apoptosis detection kit (cat no. C1065; Beyotime Institute of Biotechnology) according to the manufacturer's protocol. A total of 100 µl dye solution was added to 1x10 6 cells for resuspension. Following oscillation and mixing, the cells were incubated at room temperature for 15 min, followed by the addition of 1 ml HEPES buffer solution and oscillation. The samples were transferred on flow cytometry instrument (BD-Aria), then, bandpass filters of 525 and 620 nm were activated by 488 nm wavelength to detect FITC and PI fluorescence, in addition to cell apoptosis. Three samples were set for each group and the experiment was repeated three times.
Statistical analysis. All data were processed using SPSS 21.0 statistical software (IBM Corp., Armonk, NY, USA). The measurement data were subject to normal distribution, which was expressed as the mean ± standard deviation. The comparison of RCC and normal adjacent tissues was performed using a paired Student's t-test; the comparison between two groups was performed by an independent samples t-test and that among multiple groups by one-way analysis of variance. Tukey's post hoc test was used following analysis of variance. Numerical data were expressed as percentage or rate and analyzed using a χ 2 test. P<0.05 was considered to indicate statistically significant differences.
Results
Histopathological examination of RCC tissues and adjacent normal tissues. H&E staining was performed to observe histopathological changes. In the adjacent normal tissues, the cells exhibited normal morphology and uniform arrangement, without inflammatory infiltration. In the RCC tissues, however, the cells exhibited dedifferentiated morphology and disorderly arrangement; notable tumor cell infiltration was detected, around which normal kidney tissues were observed (Fig. 1 ). In conclusion, the cells exhibited dedifferentiated morphology and were arranged in a disorderly manner in RCC tissues compared with adjacent normal tissues.
LOXL2 protein expression is high in RCC tissues.
In order to measure the cell protein expression of LOXL2, immunohistochemistry was performed. The results (Fig. 2) revealed that LOXL2-positive cells were located in the cytoplasm, presenting as brown-yellow granules. The protein expression rate of LOXL2 in the RCC tissues was 72.5% (58/80), which was significantly higher compared with 17.5% (14/80) in adjacent normal tissues (P<0.05). Taken together, these results demonstrated that LOXL2 protein expression was higher in RCC tissues compared with that in adjacent normal tissues.
A s s o c i a t i o n s b e t we e n L OX L 2 e x p re s s i o n a n d clinicopathological characteristics of RCC.
The associations between LOXL2 expression and the clinicopathological characteristics of RCC is presented in Table III . LOXL2 expression was independent of the sex and age of patients with RCC, but was significantly associated with stage [Fuhrman (P=0.001) and TNM (P=0.009)], histological type (P=0.001), diameter (P= 0.001) and venous invasion (P= 0.002). The expression of LOXL2 was significantly elevated in patients with Fuhrman grade III + IV and those with clear cell RCC with a tumor diameter ≥4 cm (all P<0.05). Therefore, LOXL2 expression was significantly associated with tumor grade, type, diameter and venous invasion in RCC. in RCC tissues. Subsequently, RT-qPCR and western blot analysis were performed. The results (Fig. 3) demonstrated that, compared with the adjacent normal tissues, the mRNA expression levels of LOXL2, FAK, Src, MMP-9, N-cadherin and vimentin were significantly increased and the mRNA expression of E-cadherin was significantly decreased in RCC tissues (all P<0.05), whereas the protein expression levels of LOXL2, p-FAK/FAK, p-Src/Src, MMP-9, N-cadherin and vimentin were significantly increased and the protein expression of E-cadherin significantly decreased in RCC tissues (all P<0.05). Taken together, these data indicate that genes involved in LOXL2 and FAK/Src signaling pathways are highly expressed in RCC, and EMT-associated gene expression may be affected in RCC tissues. Table III . Association between LOXL2 expression and clinicopathological characteristics of renal cell carcinoma.
LOXL2 and FAK/Src signaling pathway genes are highly expressed and EMT-associated gene expression is affected
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Characteristics
Case number (n) Fig. 4B . Compared with the siRNA-NC group, the siRNA-LOXL2-1, siRNA-LOXL2-2 and siRNA-LOXL2-3 groups exhibited significantly decreased LOXL2 mRNA expression (P<0.05; Fig. 4B ) and protein expression (P<0.05; Fig. 4C ). The lowest protein expression of LOXL2 was observed in the siRNA-LOXL2-3 group, with a significantly lower expression of LOXL2 compared with the other two siRNA groups (P<0.05), indicating that the siRNA-LOXL2-3 group had the highest interference efficiency. Therefore, the plasmid in the siRNA-LOXL2-3 group was selected for further experimentation. Following Caki1 cell transfection with LOXL2 overexpression plasmids, the mRNA and protein expression of LOXL2 increased significantly compared with the blank control (P<0.05; Fig. 4D and E) . Therefore, 786-O cells were selected for siRNA experiments and Caki1 cells for overexpression experiments. Transfection efficiency. Cell transfection was performed to measure green fluorescence in cells. Following cell transfection, no green fluorescence was observed in the normal, blank and PP2 groups under a fluorescence microscope. However, intense green fluorescence was observed in the cells of the si-NC, si-LOXL2, empty vector and LOXL2 vector groups (expression rate, >80%), indicating that the adenovirus vector was successfully transfected into the RCC cells and kidney tubular epithelial cells and effectively expressed in these cells (Fig. 5) .
Silencing LOXL2 inhibits the activation of the FAK/Src pathway and EMT in RCC cells.
Next, RT-qPCR and western blot analysis were used to determine mRNA and protein expression of associated genes and proteins, respectively. As presented in Fig. 6 , the results demonstrated that following the transfection of 786-O cells, the mRNA and protein expression of LOXL2, FAK, Src, MMP-9, N-cadherin and vimentin were significantly reduced and that of E-cadherin was significantly increased in the si-LOXL2 group compared with the blank and si-NC groups (P<0.05). Following the transfection of Caki1 cells, the mRNA and protein expression of LOXL2, FAK, Src, MMP-9, N-cadherin and vimentin were significantly increased and that of E-cadherin was significantly decreased in the LOXL2 vector group compared with the blank and empty vector groups (all P<0.05; Fig. 6 ). In the PP2 group, gene expression changes exhibited the opposite trend compared with the LOXL2 vector group, except for LOXL2 which demonstrated a similar trend. In comparison with the cells in the LOXL2 vector group, the mRNA and protein expressions of p-FAK/FAK, p-Src/Src, MMP-9, N-cadherin and vimentin were significantly decreased, and that of E-cadherin was significantly increased in the LOXL2 vector + PP2 group (all P<0.05; Fig. 6 ). The aforementioned data indicated that silencing LOXL2 inhibits the activation of the FAK/Src signaling pathway and of MMP-9 and EMT. Additionally, PP2, as a FAK/Src signaling pathway inhibitor, reversed the effect of LOXL2 vector on Caki1 cells. Consequently, activation of the FAK/Src pathway and EMT may be inhibited by silencing LOXL2 in RCC cells.
Silencing of LOXL2 inhibits the proliferation of RCC cells.
Cell proliferation was assessed with an MTT assay and the results revealed differences in cell proliferation at 24, 48 and 72 h in each group. Compared with the cells in the blank and si-NC groups, the cell proliferation was significantly inhibited at all time points once 786-O cells were transfected with si-LOXL2 (P<0.05; Fig. 7A ). This indicates that the cell proliferation ability was repressed when LOXL2 expression was inhibited. In comparison with the cells in the blank and empty vector groups, once Caki1 cells were transfected with the LOXL2 vector, cell proliferation was significantly increased, while in the PP2 group it was significantly decreased (P<0.05; Fig. 7B) . Additionally, the cell proliferation ability in the LOXL2 vector + PP2 group was significantly decreased compared with cells in the LOXL2 vector group (P<0.05; Fig. 7B ). These data indicate that cell proliferation decreases when LOXL2 expression and the activation of the FAK/Src pathway are inhibited, and PP2 may reverse the effects of LOXL2 on the proliferation of RCC cells. In brief, silencing LOXL2 represses RCC cell proliferation.
Silencing LOXL2 inhibits the invasion of RCC cells. A
Transwell assay was used to analyze the invasion of cells in each group. Compared with cells in the blank group, the number of invading cells was decreased significantly once 786-O cells were transfected with si-LOXL2 (P<0.05; Fig. 8A and B) . The results demonstrated that silencing LOXL2 inhibited the invasion of RCC cells. Compared with cells in the blank and empty vector groups, the number of invading cells was significantly increased once Caki1 cells were transfected with LOXL2 vector (P<0.05), whereas that in the PP2 group was significantly decreased (P<0.05). In comparison with cells in the LOXL2 vector group, the number of invading cells in the LOXL2 vector + PP2 group was decreased significantly (P<0.05; Fig. 8C and D) . The results revealed that cell invasion ability decreases when LOXL2 expression and the activation of the FAK/Src pathway are inhibited. In addition, PP2 is able to reverse the effects of LOXL2 on the invasion ability of RCC cells. In conclusion, LOXL2 silencing inhibits RCC cell invasion.
Silencing of LOXL2 inhibits the migration of RCC cells.
A wound healing test was applied to detect cell migration. The results are presented in Fig. 9A and B. Once the 786-O cells were transfected with si-LOXL2, the cell migration ability was significantly weakened (P<0.05). Therefore, silencing LOXL2 may inhibit the migration of RCC cells. By contrast, once Caki1 cells were transfected with LOXL2 vector, cell migration ability was enhanced significantly compared with cells in the blank and empty vector groups (P<0.05), whereas the cell migration ability in the PP2 and PP2 + LXOL2 vector groups was significantly reduced (both P<0.05). Compared with cells in the LOXL2 vector group, the cell migration ability in the LOXL2 vector + PP2 group was significantly decreased (P<0.05; Fig. 9C and D) . The results demonstrated that inhibition of LOXL2 expression and inactivation of the FAK/Src pathway inhibited the migration of RCC cells, and PP2 was able to reverse the effects of LOXL2 on cell # P<0.05 vs. the LOXL2 vector group. One-way analysis of variance was used for comparison and the experiment was repeated three times. LOXL2, lysyl oxidase-like 2; Src, steroid receptor coactivator; FAK, focal adhesion kinase; MMP, matrix metalloproteinase; NC, negative control; P-, phosphorylated; si-, small interfering RNA; N-cadherin, neuronal cadherin; E-cadherin, epithelial cadherin.
migration. In conclusion, the experimental data indicate that the migration of RCC cells may be suppressed by LOXL2 silencing.
Silencing of LOXL2 inhibits the cell cycle distribution and promotes the apoptosis of RCC cells. The cell cycle detection of RCC cells was performed by flow cytometry (Fig. 10A and B) . The results demonstrated that, compared with cells in the blank group, once 786-O cells were transfected with si-LOXL2, there were a significantly higher number of cells at the G1 phase, and a significantly lower number in the S and G2/M phases (P<0.05), indicating that silencing LOXL2 may inhibit cell cycle distribution in RCC cells. In comparison with cells in the blank and empty vector groups, once Caki1 cells were transfected with LOXL2 vector, a significantly fewer number of cells were arrested at the G1 phase and a significantly greater number of cells were arrested at the S and G2/M phases (all P<0.05). The number of cells at the G1 phase increased significantly, and decreased significantly at the S and G2/M phases, in the PP2 group compared with the blank, empty vector and LOXL2 vector groups (all P<0.05). Compared with cells in the LOXL2 vector group, in the LOXL2 vector + PP2 group, a significantly greater number of cells were arrested at the G1 phase and significantly fewer cells at the S and G2/M phases (all P<0.05; Fig. 10C and D) , indicating that suppression of LOXL2 expression and inactivation of the FAK/Src pathway may reduce the percentage of RCC cells at the S phase.
Apoptosis of RCC cells was assessed by flow cytometry. The results indicated that, compared with cells in the blank group, once 786-O cells were transfected with si-LOXL2, cell apoptosis increased significantly (P<0.05; Fig. 10E and F) . Once Caki1 cells were transfected with the LOXL2 vector, cell apoptosis was significantly decreased (P<0.05), whereas that in the PP2 and PP2 + LOXL2 vector groups was significantly increased (P<0.05) compared with the blank and empty vector groups. Additionally, compared with cells in the LOXL2 vector group, cell apoptosis in the LOXL2 vector + PP2 group was significantly increased (Fig. 10G and H). These data suggest that, if the LOXL2 expression and activation of the FAK/Src pathway are inhibited, the apoptosis of RCC cells is promoted. Therefore, PP2 reverses the effect of LOXL2 on RCC cell apoptosis. In conclusion, LOXL2 silencing inhibits the cell cycle distribution and promotes the apoptosis of RCC cells.
Discussion
RCC is commonly a fatal malignancy due to late diagnosis and poor treatment options (21) . The aim of the present study was to investigate the effects and potential mechanisms of action of LOXL2 on the EMT and proliferation and invasion of RCC cells through the Src/FAK signaling pathway.
The results demonstrated that the expression of LOXL2 in RCC tissues was increased compared with that in adjacent normal tissues. The expression of LOXL2 was detected in renal tissue and in tubular epithelial cells in human kidneys, and LOXL2 functions as a promoter for the progression of tubulointerstitial fibrosis (22) . A previous study reported that, in comparison with adjacent non-cancerous renal tissues, LOXL2 was substantially elevated in specimens of human clear cell RCC (23) . Furthermore, the expression of LOX in the kidney was revealed to be markedly elevated in hyperuricemia, which is associated with renal diseases (24) .
According to the results of the clinicopathological characteristics analysis, LOXL2 expression was revealed to be associated with tumor grade, stage (Fuhrman and TNM), type, diameter and venous invasion. The expression of LOXL2 was increased in patients with tumor grade III-IV, a tumor diameter ≥4 cm and venous invasion. RCC staging is mainly based on the TNM staging system, which, together with tumor grade, provides necessary information regarding treatment and prognosis (25) . At the time of symptomatic diagnosis, 30-40% of patients with RCC will have already developed metastasis to the lymph nodes or other organs (4) . Although patients with RCC have a 5-year survival rate of 85%, ~1/3 of patients are diagnosed with a metastatic or advanced stage of the disease, with a 5-year survival rate of 10% (26) . A previous study reported that high LOX protein expression was associated with the occurrence and number of lymph node metastases (27) . In addition, the high expression of LOXL2 has been reported to be associated with the poor prognosis of patients with colon cancer, and it may be applied in clinical practice for risk classification (28) .
The Src/FAK signaling pathway-associated genes FAK and Src exhibited increased expression in RCC cells compared with # P<0.05 vs. the LOXL2 vector group. One-way analysis of variance was used for comparison and the experiment was repeated three times. LOXL2, lysyl oxidase-like 2; NC, negative control; si-, small interfering RNA. migration and metastasis (30) . The mRNA expression of Src was high in RCC samples compared with that in normal kidney samples, and Src may promote the occurrence of malignant phenotypes of RCC due to the resistance to apoptosis induced by B-cell lymphoma-extra large and angiogenesis by Src/signal transducer and activator of transcription 3 (STAT3)/vascular endothelial growth factor signaling (31) . FAK has been detected in adult RCC tissues, and it is has also been hypothesized to be involved in pediatric renal tumor types through affecting cell survival (32) .
A key result of the present study was that, compared with the blank group, the expression of FAK, Src, MMP-9, N-cadherin and vimentin was substantially decreased in the si-LOXL2 and PP2 groups, while the expression of E-cadherin was notably increased, indicating that the silencing of LOXL2 may inactivate the Src/FAK signaling pathway and inhibit EMT. LOXL2, through biochemical and biomechanical mechanisms, is capable of stimulating tumor development, potentially by activating a diverse range of signaling pathways (12) . According to a previous report, secreted LOXL2 and LOXL4 were revealed to regulate the Src/FAK signaling pathway in gastric cancer (33, 34) . LOX may also affect colorectal cancer by mechanisms involving Src and FAK (35, 36) . MMP-9 serves a pivotal role in tumor angiogenesis, cell invasion and migration, in addition to EMT regulation (37, 38) . EMT is generally considered to participate in cancer progression and metastasis (39) . N-cadherin is considered to be the mesenchymal marker in the process of EMT; E-cadherin loss and vimentin gain are two crucial steps in EMT (40, 41) . LOXL2 promotes invasion by regulating the expression and activity of the extracellular protein tissue inhibitor of MMP-9 (42). Furthermore, accumulating evidence indicates that LOXL2 downregulates E-cadherin expression and stimulates EMT (43) . The Src/FAK signaling pathway may also participate in the EMT of thyroid cancer cells (44) . LOXL2 in breast cancer cells has been demonstrated to activate oncogenic signaling pathways, resulting in EMT by extracellular in addition to intracellular mechanisms (45) . Therefore, it has been hypothesized that LOXL2 silencing may inhibit EMT in RCC cells via downregulating the Src/FAK signaling pathway.
Another notable observation of the present study was that silencing of LOXL2 inhibits RCC cell migration and invasion though the inactivation of the Src/FAK signaling pathway. The inactivation of the Src/STAT3 signaling pathway may induce apoptosis of human renal carcinoma Caki1 cells (46) . FAK/Src signaling serves a crucial role in the invasion of neoplastic cells (47) . LOXL2, a member of an amine oxidase family, has been suggested to be implicated in cross-link formation in stromal collagens and elastin, cell motility, and tumor formation and progression (48) . The inhibition of LOXL2 substantially inhibits cancer cell migration and invasion in RCC (49) . LOXL2 expression in stromal fibroblasts was also revealed to be associated with the depth of tumor invasion, lymphatic and venous invasion, in addition to peritoneal dissemination in gastric cancer (50) .
In conclusion, the results of the present study indicated that LOXL2 silencing inhibits the EMT, proliferation and invasion of RCC cells through the Src/FAK signaling pathway, which may provide a novel approach to the treatment of RCC. However, the specific mechanisms have yet to be fully elucidated and the sample size of the present study was limited; therefore, further investigation is required.
